JamesD.BrooksMD

Urology • Stanford, CA

Professor, Urology, Stanford University Medical Center

Join to view full profile

Dr. Brooks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brooks' full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Education & Training

Johns Hopkins UniversityResidency, Urology, 1990 - 1994
Johns Hopkins UniversityResidency, Surgery, 1988 - 1990
Stanford University School of MedicineClass of 1988

Certifications & Licensure

CA State Medical License 1997 - 2025
MD State Medical License 1991 - 2000
American Board of Urology Urology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Microarray Analysis of Gene Expression in Prostate Tissues Start of enrollment: 1999 Apr 06
Active, not recruiting
Quality of Life Following Radical Prostatectomy Start of enrollment: 2002 Sep 01
Completed
Prostate Active Surveillance Study Start of enrollment: 2008 Jul 01
Recruiting
Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study Start of enrollment: 2014 Feb 01
Completed
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia Start of enrollment: 2013 Jul 01
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake.
Nita H Mukand, Ekaterina Chirikova, Daphne Lichtensztajn, Serban Negoita, Tamer Aboushwareb
Cancer. 2024-12-15
1 citations
Mortality Risks Associated with Depression in Men with Prostate Cancer.
Casey Crump, Pär Stattin, James D Brooks, Jan Sundquist, Weiva Sieh
European Urology Oncology. 2024-12-01
2 citations
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group...
Jane K Nguyen, Lara R Harik, Eric A Klein, Jianbo Li, Dillon Corrigan
Histopathology. 2024-10-01

Press Mentions

These New, $300,000,000 Cancer Treatment Centers Are Saving Lives -- but Questions Linger About Cost and Efficacy | SurvivorNetJuly 26th, 2019
Two Genes Implicated in Development of Prostate EnlargementJune 14th, 2019